PSMG3 Antibody, FITC conjugated
-
中文名稱：PSMG3兔多克隆抗體, FITC偶聯(lián)
-
貨號(hào)：CSB-PA861132LC01HU
-
規(guī)格：￥880
-
其他：
產(chǎn)品詳情
-
產(chǎn)品名稱：Rabbit anti-Homo sapiens (Human) PSMG3 Polyclonal antibody
-
Uniprot No.：
-
基因名：PSMG3
-
別名：C7orf48 antibody; hPAC3 antibody; MGC10911 antibody; PAC 3 antibody; PAC-3 antibody; PAC3 antibody; Proteasome (prosome macropain) assembly chaperone 3 antibody; Proteasome assembly chaperone 3 antibody; PSMG 3 antibody; PSMG3 antibody; PSMG3_HUMAN antibody
-
宿主：Rabbit
-
反應(yīng)種屬：Human
-
免疫原：Recombinant Human Proteasome assembly chaperone 3 protein (1-122AA)
-
免疫原種屬：Homo sapiens (Human)
-
標(biāo)記方式：FITC
-
克隆類型：Polyclonal
-
抗體亞型：IgG
-
純化方式：>95%, Protein G purified
-
濃度：It differs from different batches. Please contact us to confirm it.
-
保存緩沖液：Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 -
產(chǎn)品提供形式：Liquid
-
儲(chǔ)存條件：Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期：Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途：For Research Use Only. Not for use in diagnostic or therapeutic procedures.
產(chǎn)品評(píng)價(jià)
相關(guān)產(chǎn)品
靶點(diǎn)詳情
-
功能：Chaperone protein which promotes assembly of the 20S proteasome. May cooperate with PSMG1-PSMG2 heterodimers to orchestrate the correct assembly of proteasomes.
-
基因功能參考文獻(xiàn)：
- we report the identification of a chaperone, designated PAC3, as a component of alpha rings. PAC3 dissociates before the formation of half-proteasomes, a process coupled with the recruitment of beta subunits and hUmp1.[PAC3] PMID: 17189198
-
蛋白家族：PSMG3 family
-
數(shù)據(jù)庫鏈接：
Most popular with customers
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-
-
